• Medicine · Jul 2015

    Prompt Oseltamivir Therapy Reduces Medical Care and Mortality for Patients With Influenza Infection: An Asian Population Cohort Study.

    • Chang-Bi Wang, Mu-Lin Chiu, Po-Chang Lin, Wen-Miin Liang, Chiu-Ying Chen, Yu-Jun Chang, Trong-Neng Wu, Jen-Hsien Wang, and Fung-Chang Sung.
    • From the Department of Public Health, China Medical University, Taichung (C-BW, M-LC, P-CL, W-ML, C-YC, Y-JC, T-NW, F-CS); Institute of Population Health Sciences, National Health Research Institutes, Zhunan (M-LC); Department of Internal Medicine, Division of Infectious Diseases, China Medical University Hospital (P-CL, J-HW); Graduate Institute of Biostatistics, Biostatistics Center, China Medical University, Taichung (W-ML); Epidemiology and Biostatistics Center, Changhua Christian Hospital, Changhua (Y-JC); Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan (F-CS).
    • Medicine (Baltimore). 2015 Jul 1; 94 (27): e1070e1070.

    AbstractThere are limited population-based studies on the progress of oseltamivir therapy for influenza infection.Using insurance claims data of 2005, 2009, and 2010, the authors established an "in-time" cohort and a "lag-time" cohort representing influenza patients taking the medicine within and not within 1 week to examine the treatment progress. Incident outpatient visit, emergency care and hospitalization, and fatality were compared between the 2 cohorts in the first week and the second week of follow-up periods, after the oseltamivir therapy.A total of 112,492 subjects diagnosed with influenza on oseltamivir therapy in 2005, 2009, and 2010 were identified. The multivariate logistic regression analysis showed that the in-time treatment was superior to the lag-time treatment with less repeat outpatient visits, hospitalizations, and fatality. The overall corresponding in-time treatment to lag-time treatment odds ratios (OR) were 0.50, 0.54, and 0.71 (all P value < 0.05), respectively. The in-time to lag-time ORs of all events were 0.50 in 2009 and 0.54 in 2010.Our study demonstrates that the in-time oseltamivir therapy leads to significantly better treatment outcomes. Oseltamivir should be administered as early as the onset of influenza symptoms appears.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…